Dhampur Bio Organics
Dhampur Bio Organics (DBOL) share price was ₹126.14 at the 28 Oct 2026 close; market capitalisation ₹837 Cr; P/E (TTM) 9.97; sector Consumer Goods. The share price rose 57.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 8.2% year on year to ₹532.9 Cr and net profit was ₹37 Cr, against −₹22 Cr a year earlier (compared with Jun 2025). Promoters held 51.00% of Dhampur Bio Organics in Sep 2026, up 0.22 percentage points from Jun 2026. Its Tapetide Score is 58/100 (Good) as of 28 Oct 2026.
Key Fundamentals
MicrocapConsumer GoodsFMCGPrice-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM
Peer Comparison
Fast Moving Consumer Goods › Consumer Goods › Sugar
| ₹633.20 | 34.64 | 13,398 Cr | 2.92 | 0.55% | 9.15% | 11.80% | 6,444 Cr | 371 Cr | |
| ₹224.99 | 17.93 | 4,958 Cr | 1.48 | 1.21% | 8.04% | 11.91% | 6,275 Cr | 270 Cr | |
| ₹17.82 | 99.00 | 4,260 Cr | 4.46 | 0.00% | 3.31% | 1.93% | 5,353 Cr | 116 Cr | |
| ₹3,143.50 | 32.38 | 3,942 Cr | 2.06 | 0.40% | 7.73% | 8.78% | 1,716 Cr | 122 Cr | |
| ₹18.33 | — | 3,902 Cr | — | 0.00% | 29.60% | -16.88% | 9,409 Cr | -780 Cr | |
| ₹406.50 | 15.88 | 3,290 Cr | 1.01 | 1.46% | 7.28% | 9.59% | 3,636 Cr | 207 Cr | |
| ₹824.60 | 25.03 | 1,651 Cr | 1.47 | 1.23% | 5.10% | 10.35% | 2,764 Cr | 66 Cr | |
| Dhampur Bio Organics (this company) | ₹126.14 | 9.97 | 837 Cr | 0.82 | 1.23% | 2.45% | 7.93% | 2,126 Cr | 84 Cr |
| Median 8 companies | ₹315.75 | 25.03 | 3,922 Cr | 1.48 | 0.88% | 7.51% | 9.19% | 4,495 Cr | 119 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Stock is trading at 0.84 times its book value
- Company has been maintaining a healthy dividend payout of 43.9%
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of 2.61% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.89.5 Cr.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 1.7% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 583 | 538 | 280 | 463 | 467 | 466 | 464 | 464 | 492 | 558 | 486 | 460 | 533 |
| Expenses | 543 | 519 | 284 | 382 | 434 | 476 | 448 | 369 | 484 | 566 | 444 | 380 | 524 |
| Operating Profit | 41 | 19 | -4 | 81 | 33 | -10 | 16 | 96 | 9 | -8 | 43 | 80 | 9 |
| OPM % | 7% | 3.6% | -1.6% | 18% | 7% | -2.1% | 3.4% | 21% | 1.8% | -1.4% | 9% | 17% | 1.7% |
| Other Income | 2 | 1 | 16 | 5 | 1 | 1 | -1 | 1 | -6 | 13 | 9 | 15 | 52 |
| Interest | 13 | 9 | 6 | 18 | 21 | 16 | 10 | 20 | 19 | 14 | 11 | 14 | 16 |
| Depreciation | 11 | 10 | 14 | 14 | 12 | 11 | 15 | 16 | 12 | 15 | 15 | 13 | 13 |
| PBT | 18 | 0 | -8 | 54 | 1 | -35 | -10 | 61 | -29 | -23 | 26 | 69 | 32 |
| Tax % | 32% | 88% | -28% | 28% | 83% | -34% | -32% | 26% | -24% | -32% | 34% | 33% | -14% |
| Net Profit | 13 | 0 | -6 | 39 | 0 | -23 | -7 | 45 | -22 | -16 | 17 | 46 | 37 |
| EPS (₹) | 1.91 | 0.01 | -0.85 | 5.94 | 0.02 | -3.52 | -1.03 | 6.75 | -3.31 | -2.41 | 2.55 | 6.97 | 5.54 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 1,564 | 2,408 | 1,864 | 1,862 | 2,109 | 2,036 |
| Expenses | 0 | 1,381 | 2,203 | 1,724 | 1,727 | 1,976 | 1,913 |
| Operating Profit | 0 | 183 | 205 | 140 | 135 | 133 | 124 |
| OPM % | — | 12% | 8% | 8% | 7% | 6% | 6% |
| Other Income | 0 | 8 | 11 | 20 | 2 | 29 | 89 |
| Interest | 0 | 30 | 41 | 45 | 67 | 63 | 54 |
| Depreciation | 0 | 31 | 41 | 49 | 54 | 59 | 55 |
| PBT | 0 | 129 | 135 | 65 | 16 | 41 | 103 |
| Tax % | 0% | 21% | 18% | 29% | 6% | 38% | — |
| Net Profit | 0 | 102 | 111 | 46 | 15 | 25 | 84 |
| EPS (₹) | — | — | 16.74 | 7 | 2.21 | 3.79 | 12.65 |
| Div. Payout % | 0% | 0% | 21% | 36% | 56% | 40% | — |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 66 | 66 | 66 | 66 | 66 | 66 |
| Reserves | 709 | 812 | 922 | 945 | 945 | 960 |
| Borrowings | 403 | 835 | 810 | 1,057 | 1,162 | 1,060 |
| Other Liabilities | 373 | 287 | 278 | 244 | 223 | 235 |
| Total Liabilities | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 2,322 |
| Fixed Assets | 631 | 690 | 909 | 1,036 | 1,076 | 1,131 |
| CWIP | 7 | 78 | 36 | 13 | 79 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 913 | 1,232 | 1,132 | 1,263 | 1,242 | 1,188 |
| Total Assets | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 2,322 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | -246 | 368 | -101 | 130 | 220 |
| Investing | 0 | -124 | -209 | -166 | -145 | -42 |
| Financing | 0 | 393 | -78 | 170 | 19 | -178 |
| Net Cash Flow | 0 | 23 | 81 | -98 | 3 | 0 |
| Free Cash Flow | 0 | -389 | 158 | -245 | -15 | 177 |
| CFO/EBITDA | 100 | -122 | 191 | -60 | 102 | 164 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 25 | 23 | 17 | 11 | 11 |
| Inventory Days | — | 341 | 163 | 288 | 288 | 231 |
| Days Payable | — | 54 | 33 | 37 | 29 | 26 |
| Cash Conversion Cycle | — | 312 | 154 | 269 | 270 | 216 |
| Working Capital Days | — | 56 | 24 | 33 | 21 | 23 |
| ROCE % | — | 11% | 10% | 5% | 4% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Dhampur Bio Organics insights
63 extracted metrics + investor summaries across FY21–FY27.
Documents
Frequently Asked Questions about Dhampur Bio Organics
What does Dhampur Bio Organics Ltd do?
Where is Dhampur Bio Organics Ltd (DBOL) listed?
Which sector does Dhampur Bio Organics Ltd belong to?
What is the market capitalisation of Dhampur Bio Organics Ltd?
What is the PE ratio of Dhampur Bio Organics Ltd?
What is the 52-week high and low of Dhampur Bio Organics Ltd?
Does Dhampur Bio Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Dhampur Bio Organics Ltd?
Company Information
Incorporated in 2022, Dhampur Bio Organics Ltd manufactures sugar, chemicals, ethanol, co-generation of power and other allied products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DBOL.md for Dhampur Bio Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.